Key Moments
Particle Physics Might Just Save Your Life – Public lecture by Dr. Jennifer L. Raaf
FermilabKey Moments
Particle physics research led to life-saving medical tech, including cancer therapies and COVID-19 ventilators.
Key Insights
Fundamental particle physics research unexpectedly yields practical medical applications.
Proton therapy, developed from particle physics understanding, offers precise cancer treatment.
Fermilab's history includes developing radiation therapy facilities and technologies.
The Mechanical Ventilator Milano (MVM) was rapidly designed by particle physicists to address COVID-19 ventilator shortages.
The MVM prioritized affordability, reliability, and ease of manufacturing, using off-the-shelf components.
Rigorous testing and regulatory approval were crucial for the MVM's deployment.
Particle physicists' skills in systems design, data acquisition, and software development are transferable to medical device creation.
FROM FUNDAMENTAL RESEARCH TO PRACTICAL APPLICATIONS
Dr. Jennifer Raaf's talk addresses the common question of how fundamental particle physics research benefits everyday life. She explains that while the primary goal is understanding the universe's mysteries, this pursuit often leads to the development of technologies with significant practical applications. Many medical tools used today, from MRI technology enabled by superconducting magnets to particle beam therapies, originated from this fundamental research, demonstrating an indirect but profound link between exploring the cosmos and improving human health.
THE EVOLUTION OF RADIATION THERAPY
The talk delves into the history of radiation therapy, highlighting how particle physics has shaped cancer treatment. Early use of X-rays has evolved into sophisticated methods using particle beams. A pivotal moment was Robert Wilson's 1946 proposal for proton therapy, leveraging the unique energy deposition characteristic known as the Bragg peak. This physics principle allows for precise targeting of tumors, minimizing damage to surrounding healthy tissues, a significant advancement over earlier methods.
PARTICLE THERAPIES: MECHANISMS AND CONSIDERATIONS
Understanding different radiation therapies involves considering particle type, energy deposition, and biological effects. Low Linear Energy Transfer (LET) radiation, like X-rays and protons, damages cells primarily through ionization, offering a chance for repair. High LET radiation, such as neutrons, causes more extensive damage, making cellular repair less likely. Factors like the Bragg peak's depth control, LET, and Relative Biological Effectiveness (RBE) are crucial for oncologists in selecting the most effective treatment, alongside cost considerations.
FERMILAB'S CONTRIBUTIONS TO RADIATION THERAPY
Fermilab has been instrumental in developing radiation therapy. The Fermilab Neutron Therapy Facility, operational from 1976 to 2013, treated over 3,000 patients. Additionally, Fermilab designed and constructed the first hospital-based proton accelerator in the US for Loma Linda University Medical Center, which has treated over 21,500 patients since 1990 and inspired numerous other centers worldwide. These initiatives showcase Fermilab's direct impact on cancer treatment.
RAPID RESPONSE TO A GLOBAL PANDEMIC: THE MVM VENTILATOR
In response to the urgent need for ventilators during the COVID-19 pandemic, a team of over 100 particle physicists, medical experts, and engineers collaborated to design the Mechanical Ventilator Milano (MVM). Recognizing that fundamental principles of gas regulation in physics experiments share similarities with ventilator functions, the team rapidly developed a prototype. Their goal was to create a low-cost, reliable, and easily manufacturable device that could be deployed globally.
DESIGN PRINCIPLES AND TECHNICAL SPECIFICATIONS OF THE MVM
The MVM was designed with four core principles: low cost (targeting $5,000-$6,000, significantly less than commercial units), robustness, ease of manufacturing, and an open-access design. It utilizes off-the-shelf components and a simple, electromechanical system requiring only pressurized air/oxygen and electricity. The device features a microcomputer controlling valves based on sensor feedback, displaying real-time data like pressure, volume, and flow, and includes alarm systems to ensure patient safety.
TESTING, APPROVAL, AND GLOBAL DEPLOYMENT
The MVM underwent extensive testing using sophisticated breathing simulators to mimic various patient lung conditions. The device achieved crucial regulatory approvals, including FDA emergency use authorization in the US and Health Canada certification. This led to a contract for 10,000 units from the Canadian government, with plans for global distribution. The rapid development, from concept to FDA approval in just 42 days, highlights the agility and effectiveness of the collaborative team.
TRANSFERABLE SKILLS AND FUTURE POTENTIAL
The MVM project exemplifies how skills honed in particle physics—such as designing complex systems, managing data acquisition, and writing intricate software—are directly applicable to critical challenges like medical device development. While the MVM's initial design focused on rapid deployment for the pandemic, future iterations by manufacturers may incorporate additional features. The success of the MVM demonstrates the profound, life-saving potential that arises when fundamental science expertise is applied to urgent societal needs.
Mentioned in This Episode
●Products
●Software & Apps
●Tools
●Companies
●Organizations
●Books
●Concepts
●People Referenced
Common Questions
Fundamental research often leads to the development of new technologies and understanding of physical processes. These can later be adapted for practical applications, such as medical imaging (MRI) or radiation therapy, which arose from investigating particle interactions.
Topics
Mentioned in this video
A radiation therapy facility at Fermilab that used fast neutron therapy from 1976 to 2013, treating over 3,000 patients.
A low-cost, ventilator designed and built by physicists in response to the COVID-19 pandemic.
An early positive pressure ventilator developed by Forrest Bird, widely used in the US.
A sophisticated breathing simulator used to test the MVM's performance under various lung conditions.
Mentioned as someone who helped gather images and information for the lecture.
Mentioned as someone who helped gather images and information for the lecture.
Director of Loma Linda University Medical Center who initiated the partnership with Fermilab for a proton therapy facility.
Mentioned as someone who helped gather images and information for the lecture.
Deputy Director of Fermilab who worked on the proton accelerator project for Loma Linda and later became a patient there.
Professor of Physics at Princeton and Italian colleague who initiated the effort to develop ventilators amid the COVID-19 pandemic.
An early Fermilab employee involved in building the Neutron Therapy Facility, who later successfully received neutron therapy there for prostate cancer.
Developed a gas-driven ventilator in London, which became popular in Europe.
Inventor of the Bird ventilator, an early and influential positive pressure ventilator.
The CIO of Fermilab and host of the lecture.
Senior scientist and head of the DUNE Department in the Neutrino Division at Fermilab, the speaker of the lecture.
A characteristic feature of charged particles like protons, where they deposit most of their energy at a specific depth before coming to a stop.
A method of treating cancer by directing beams of particles at cancerous cells to damage their DNA.
A measure of how much damage a particle does per unit length of its path, distinguishing between low LET (photons, electrons, protons) and high LET (neutrons, ions) radiation.
The regulatory body that granted emergency use authorization for the MVM ventilator.
The institution that partnered with Fermilab to build the first hospital-based proton accelerator for cancer therapy in the US.
The Canadian regulatory body that granted approval for the MVM ventilator, including a contract for 10,000 units.
Hosted a testing site for the MVM in Chicago.
Provided grants that supported the start of fast neutron therapy in the US and partnered with Fermilab for the Neutron Therapy Facility.
A testing site for the MVM prototype in Canada.
Governing body for CE marking in the European Union, whose approval is also sought for the MVM.
More from Fermilab
View all 57 summaries
8 minIs dark matter hiding in the neutrino fog? | Even Bananas
2 minThe Dark Energy Survey | Investigating how the universe expands
79 minScientific Seminar: MicroBooNE finds no evidence for a single sterile neutrino
2 minMicroBooNE | Studying the elusive neutrino
Found this useful? Build your knowledge library
Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.
Get Started Free